Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.
- NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_assertion description "[NAT2 slow metabolizers are more prone to the side effects of polymorphically acetylated drugs, as is the SLE-like syndrome induced by hydralazine and procainamide, the side effects due to sulphasalazine and the skin rash secondary to many sulphonamides.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.
- NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_assertion evidence source_evidence_literature NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.
- NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_assertion SIO_000772 18680473 NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.
- NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_assertion wasDerivedFrom befree-2016 NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.
- NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_assertion wasGeneratedBy ECO_0000203 NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.
- befree-2016 importedOn "2016-02-19" NP686119.RA3zfpSCPj9CyKLk1PBtMXRkPMPu_RJAcPjJqcRhxcHGM130_provenance.